ENTITY
SK Biopharmaceuticals

SK Biopharmaceuticals (326030 KS)

121
Analysis
Health CareSouth Korea
SK Biopharmaceuticals Co., Ltd. researches and develops new drugs. The Company develops and markets brain disorders treatment drugs, central nervous system disorders treatment drugs, and other products. SK Biopharmaceuticals markets its products worldwide.
more
Refresh
15 Jun 2020 12:13

SK Biopharm Valuation Analysis (What Is the Market Implying from SK Holdings?)

In this insight, we provide a valuation analysis of SK Biopharmaceuticals (BIO SK).Bullish Case Valuation - If we take a bullish case valuation...

Logo
334 Views
Share
11 Jun 2020 02:55

SK Biopharmaceuticals IPO: Potential Overhang Issue by SK Holdings

First, let me tell you this. The mood seems super hot on the SK Biopharm IPO. The book-building (overseas) is now in progress.And we are already...

Logo
398 Views
Share
03 Jun 2020 07:57

SK Biopharmaceuticals - Fast Index Entry Possibilities

SK Biopharmaceuticals (BIO SK) could reopen the Korean IPO market with its listing that is expected later this month. With 19.58m shares being...

Logo
474 Views
Share
01 Jun 2020 08:10

Korea Stock Market Monthly Recap #48 (May 2020)

Review of Top 10 Issues Related to Korean stock market, economy, & politics in May 2020 Big interest in SK Biopharm IPO Announcements of IPOs...

Logo
298 Views
Share
27 May 2020 06:56

SK Biopharmaceuticals IPO: Betting on Early Inclusion in KOSPI 200?

When it comes to the local street's investment mood in Korea, I usually visit two news websites. They are Invest Chosun and MoneyToday the Bell....

Logo
368 Views
Share
x